Amryt Pharma plc [AMYT] vs UnitedHealth [UNH] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 21 vital metrics comparison: Amryt Pharma plc wins in 3 metrics, UnitedHealth Group Incorporated wins in 10 metrics, with 2 ties. UnitedHealth Group Incorporated appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Amryt Pharma plc | UnitedHealth Group Incorporated | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 39.73 | 26.81 | UnitedHealth Group Incorporated |
| Price-to-Book Ratio | 2.80 | 3.42 | Amryt Pharma plc |
| Debt-to-Equity Ratio | 164.32 | 73.98 | UnitedHealth Group Incorporated |
| PEG Ratio | -0.39 | -0.27 | UnitedHealth Group Incorporated |
| EV/EBITDA | 0.00 | 17.29 | Tie |
| Profit Margin (TTM) | 52.32% | 2.68% | Amryt Pharma plc |
| Operating Margin (TTM) | -0.86% | 8.05% | UnitedHealth Group Incorporated |
| EBITDA Margin (TTM) | N/A | 8.05% | N/A |
| Return on Equity | -94.18% | 12.18% | UnitedHealth Group Incorporated |
| Return on Assets (TTM) | -2.32% | 3.78% | UnitedHealth Group Incorporated |
| Free Cash Flow (TTM) | N/A | $16.08B | N/A |
| Dividend Yield | N/A | 3.84% | N/A |
| 1-Year Return | N/A | 30.30% | N/A |
| Price-to-Sales Ratio (TTM) | 4.24 | 0.72 | UnitedHealth Group Incorporated |
| Enterprise Value | $0 | $371.09B | UnitedHealth Group Incorporated |
| EV/Revenue Ratio | 0.00 | 0.83 | Tie |
| Gross Profit Margin (TTM) | 44.86% | 16.34% | Amryt Pharma plc |
| Revenue per Share (TTM) | $5 | $496 | UnitedHealth Group Incorporated |
| Earnings per Share (Diluted) | $0.02 | $13.24 | UnitedHealth Group Incorporated |
| Beta (Stock Volatility) | N/A | 0.41 | N/A |
| Short % of Float | N/A | 1.86% | N/A |
Amryt Pharma plc vs UnitedHealth Group Incorporated Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Amryt Pharma plc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| UnitedHealth Group Incorporated | 0.62% | 1.10% | 4.36% | 43.98% | 20.50% | 22.19% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Amryt Pharma plc | N/A | N/A | N/A | N/A | N/A | N/A |
| UnitedHealth Group Incorporated | 30.30% | -10.90% | 4.92% | 196.70% | 717.69% | 822.38% |
Performance & Financial Health Analysis: Amryt Pharma plc vs UnitedHealth Group Incorporated
| Metric | AMYT | UNH |
|---|---|---|
| Market Information | ||
| Market Cap | N/A | $322.34B |
| Market Cap Category | N/A | Mega cap |
| 10 Day Avg. Volume | 2,376,385 | 9,626,040 |
| 90 Day Avg. Volume | 1,458,182 | 9,353,900 |
| Last Close | $14.70 | $411.04 |
| 52 Week Range | $14.70 - $14.71 | $234.60 - $415.98 |
| % from 52W High | -0.07% | -1.19% |
| All-Time High | $14.71 (Jan 16, 2025) | $630.73 (Nov 11, 2024) |
| % from All-Time High | -0.07% | -34.83% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.11% | 0.02% |
| Quarterly Earnings Growth | N/A | 0.00% |
| Financial Health | ||
| Profit Margin (TTM) | 0.52% | 0.03% |
| Operating Margin (TTM) | -0.01% | 0.08% |
| Return on Equity (TTM) | -0.94% | 0.12% |
| Debt to Equity (MRQ) | 164.32 | 73.98 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $0.02 | $103.87 |
| Cash per Share (MRQ) | $1.30 | $34.32 |
| Operating Cash Flow (TTM) | $-29,023,000 | $23.15B |
| Levered Free Cash Flow (TTM) | $-18,171,000 | $17.69B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 3.84% |
| Last 12-Month Dividend | N/A | $10.94 |
Valuation & Enterprise Metrics Analysis: Amryt Pharma plc vs UnitedHealth Group Incorporated
| Metric | AMYT (Mar 31, 2025) | UNH (Apr 26, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 39.73 | 26.81 |
| Forward P/E | -490.00 | 17.17 |
| PEG Ratio | -0.39 | -0.27 |
| Price to Sales (TTM) | 4.24 | 0.72 |
| Price to Book (MRQ) | 2.80 | 3.42 |
| Market Capitalization | ||
| Market Capitalization | $942.77M | $322.34B |
| Enterprise Value | $0 | $371.09B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.00 | 0.83 |
| Enterprise to EBITDA | 0.00 | 17.29 |
| Risk & Other Metrics | ||
| Beta | N/A | 0.41 |
| Book Value per Share (MRQ) | $0.02 | $103.87 |
Financial Statements Comparison: Amryt Pharma plc vs UnitedHealth Group Incorporated
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | AMYT | UNH (2025) |
|---|---|---|
| Revenue/Sales | N/A | 447.57B |
| Cost of Goods Sold | N/A | 364.65B |
| COGS % of Revenue | - | 81.5% |
| Gross Profit | N/A | 82.92B |
| Gross Margin | - | 18.5% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | 18.96B |
| Operating Margin | - | 4.2% |
| EBITDA | N/A | 23.33B |
| EBITDA Margin | - | 5.2% |
| Pre-Tax Income | N/A | 14.70B |
| Pre-Tax Income % of Revenue | - | 3.3% |
| Income Tax | N/A | 1.89B |
| Income Tax % of Revenue | - | 0.4% |
| Net Income (Profit) | N/A | 12.81B |
| Profit Margin | - | 2.9% |
Balance Sheet & Liquidity Metrics
| Metric | AMYT | UNH (2025) |
|---|---|---|
| Cash & Equivalents | N/A | 24.37B |
| Total Current Assets | N/A | 90.58B |
| Total Current Assets % of Revenue | - | 20.2% |
| Total Current Liabilities | N/A | 114.90B |
| Total Current Liabilities % of Revenue | - | 25.7% |
| Long-Term Debt | N/A | 72.32B |
| Long-Term Debt % of Revenue | - | 16.2% |
| Total Shareholders Equity | N/A | 101.70B |
| Retained Earnings | N/A | 95.60B |
| Retained Earnings % of Revenue | - | 21.4% |
| Property, Plant & Equipment | N/A | 0 |
Cash Flow Statement Comparison
| Metric | AMYT | UNH (2025) |
|---|---|---|
| Operating Cash Flow | N/A | 13.61B |
| Operating Cash Flow % of Revenue | - | 3.0% |
| Capital Expenditures | N/A | -3.62B |
| Free Cash Flow | N/A | 16.08B |
| FCF Margin | - | 3.6% |
| Debt Repayment | N/A | -3.05B |
| Common Stock Repurchase | N/A | -5.55B |
Short Interest & Institutional Ownership Analysis
| Metric | AMYT | UNH |
|---|---|---|
| Shares Short | N/A | 15.18M |
| Short Ratio | N/A | 1.68 |
| Short % of Float | N/A | 1.86% |
| Shares Outstanding | 64.13M | 905.84M |
| Float Shares | N/A | 902.31M |
| % Held by Insiders | N/A | 0.81% |
| % Held by Institutions | N/A | 83.96% |
| % Held by Public | N/A | 15.23% |
Dividend Analysis & Yield Comparison: Amryt Pharma plc vs UnitedHealth Group Incorporated
| Metric | AMYT | UNH |
|---|---|---|
| Last 12-Month Dividend | N/A | $10.94 |
| Last 12-Month Dividend Yield | N/A | 3.84% |
| 3-Year Avg Annual Dividend | N/A | $8.25 |
| 3-Year Avg Dividend Yield | N/A | 0.50% |
| 3-Year Total Dividends | N/A | $24.76 |
| Ex-Dividend Date | N/A | Mar 09, 2026 |